Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q27853361)
Watch
English
Long Term Survival and Continued Complete Response of Vemurafenib in a Metastatic Melanoma Patient with BRAF V600K Mutation
scientific article
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
PubMed
PubMed ID
26989536
retrieved
13 November 2016
title
Long Term Survival and Continued Complete Response of Vemurafenib in a Metastatic Melanoma Patient with BRAF V600K Mutation
(English)
1 reference
stated in
PubMed
PubMed ID
26989536
retrieved
13 November 2016
main subject
patient
1 reference
based on heuristic
inferred from title
metastatic melanoma
1 reference
based on heuristic
inferred from title
author name string
K Sahadudheen
series ordinal
1
0 references
Md Rafiqul Islam
series ordinal
2
0 references
M Iddawela
series ordinal
3
0 references
publication date
2016
0 references
published in
Case Reports in Oncological Medicine
0 references
volume
2016
0 references
page(s)
2672671
0 references
copyright license
Creative Commons Attribution 4.0 International
start time
1 January 2016
1 reference
stated in
April 2022 Public Data File from Crossref
copyright status
copyrighted
1 reference
stated in
April 2022 Public Data File from Crossref
cites work
Safety and efficacy of vemurafenib in BRAF(V600E) and BRAF(V600K) mutation-positive melanoma (BRIM-3): extended follow-up of a phase 3, randomised, open-label study
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4775779
retrieved
20 March 2017
Survival in BRAF V600-mutant advanced melanoma treated with vemurafenib
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4775779
retrieved
20 March 2017
Improved survival with vemurafenib in melanoma with BRAF V600E mutation
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4775779
retrieved
20 March 2017
Mutations of the BRAF gene in human cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4775779
retrieved
20 March 2017
BRAF mutations in advanced cancers: clinical characteristics and outcomes
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4775779
retrieved
20 March 2017
Safety and efficacy of vemurafenib in end stage renal failure.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4775779
retrieved
29 September 2017
Focus on TILs: prognostic significance of tumor infiltrating lymphocytes in human melanoma
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4775779
retrieved
29 September 2017
Management of cutaneous melanoma
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4775779
retrieved
29 September 2017
The role of chemokines in melanoma tumor growth and metastasis
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4775779
retrieved
29 September 2017
Prognostic and clinicopathologic associations of oncogenic BRAF in metastatic melanoma.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1155%2F2016%2F2672671
retrieved
21 January 2018
Distinguishing Clinicopathologic Features of Patients with V600E and V600K BRAF-Mutant Metastatic Melanoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1155%2F2016%2F2672671
retrieved
21 January 2018
Vemurafenib
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/26989536
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Identifiers
DOI
10.1155/2016/2672671
1 reference
stated in
PubMed
PubMed ID
26989536
retrieved
13 November 2016
PMCID
4775779
1 reference
stated in
PubMed
PubMed ID
26989536
retrieved
13 November 2016
PubMed ID
26989536
1 reference
stated in
PubMed
PubMed ID
26989536
retrieved
13 November 2016
ResearchGate publication ID
295084174
0 references
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
